Jane Street
APYX icon

Jane Street’s Apyx Medical APYX Stock Holding History

Jane Street’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,600
Closed -$50.5K – 11042
2025
Q3 		$50.5K Buy
+23,600
New +$50K ﹤0.01% 10349

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Jane Street's APYX Position: Q1 2026 in Review

Jane Street reduced its Apyx Medical (APYX) stake by 22% in Q1 2026, selling an estimated $138K and leaving 131,297 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #8122.

Jane Street first reported a position in APYX in Q2 2021 and has held it in 6 quarters since. The position peaked at $589K in Q4 2025. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Jane Street held 131,297 shares of Apyx Medical worth $484K as of Q1 2026.
  • Jane Street sold 36,941 Apyx Medical shares in Q1 2026, an estimated $138K.
  • Apyx Medical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8122 holding.
  • Jane Street first reported a position in Apyx Medical in Q2 2021 and has held it in 6 quarters since.
  • Jane Street's Apyx Medical position peaked at $589K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.